ranimustine has been researched along with Myelomonocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imamura, M; Kunieda, Y; Kurosawa, M; Maeda, S; Miyazaki, T; Morioka, M; Okabe, M; Sakurada, K; Sukegawa, M | 1 |
1 other study(ies) available for ranimustine and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
[Therapeutic effect of ranimustine(MCNU) on myeloproliferative disorder and chronic myelomonocytic leukemia].
Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Myelomonocytic, Chronic; Male; Mercaptopurine; Middle Aged; Myeloproliferative Disorders; Nitrosourea Compounds; Remission Induction | 1991 |